1-15 of 15
Authors: Peter Bossuyt
Save search
Sort by
Journal Article

Induction of Endoscopic Response, Remission, and Ulcer-Free Endoscopy With Upadacitinib Is Associated With Improved Clinical Outcomes and Quality of Life in Patients With Crohn’s Disease Open Access

PDF
Julian Panés and others
Inflammatory Bowel Diseases, Volume 31, Issue 2, February 2025, Pages 394–403, https://doi.org/10.1093/ibd/izae200
Published: 04 September 2024
Journal Article

Mirikizumab Sustained Impact on Fatigue in Patients with Moderately to Severely Active Crohn’s Disease in the Phase 2 AMAG Study Open Access

PDF
Miguel Regueiro and others
Inflammatory Bowel Diseases, Volume 31, Issue 2, February 2025, Pages 432–441, https://doi.org/10.1093/ibd/izae166
Published: 02 August 2024
Journal Article

Real-world Effectiveness and Safety of Risankizumab in Patients with Moderate to Severe Multirefractory Crohn’s Disease: A Belgian Multicentric Cohort Study Free

PDF
Dahham Alsoud and others
Inflammatory Bowel Diseases, Volume 30, Issue 12, December 2024, Pages 2289–2296, https://doi.org/10.1093/ibd/izad315
Published: 12 January 2024
Journal Article

Recommendations for Standardizing Clinical Trial Design and Endoscopic Assessment in Postoperative Crohn’s Disease Free

PDF
Jurij Hanzel and others
Inflammatory Bowel Diseases, Volume 28, Issue 9, September 2022, Pages 1321–1331, https://doi.org/10.1093/ibd/izab259
Published: 13 November 2021
Journal Article

Corrigendum to: Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients with Crohn Disease: Posthoc Analysis of the LOVE-CD Study Open Access

PDF
Jurij Hanzel and others
Inflammatory Bowel Diseases, Volume 28, Issue 5, May 2022, Page 817, https://doi.org/10.1093/ibd/izab270
Published: 12 November 2021
Journal Article

Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients With Crohn Disease: Posthoc Analysis of the LOVE-CD Study Open Access

PDF
Jurij Hanzel and others
Inflammatory Bowel Diseases, Volume 28, Issue 5, May 2022, Pages 689–699, https://doi.org/10.1093/ibd/izab143
Published: 17 June 2021
Journal Article

Collecting New Peak and Intermediate Infliximab Levels to Predict Remission in Inflammatory Bowel Diseases Free

PDF
Claire Liefferinckx and others
Inflammatory Bowel Diseases, Volume 28, Issue 2, February 2022, Pages 208–217, https://doi.org/10.1093/ibd/izab042
Published: 30 March 2021
Journal Article

Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn’s Disease: A Post Hoc Analysis From the CALM Study Open Access

PDF
Walter Reinisch and others
Inflammatory Bowel Diseases, Volume 26, Issue 10, October 2020, Pages 1562–1571, https://doi.org/10.1093/ibd/izaa025
Published: 27 February 2020
Journal Article

Letter to the Editor: Feasibility and Efficiency of an E-Health Preadmission Assessment System for Intravenous Therapy in Inflammatory Bowel Disease Get access

PDF
Lieven Pouillon and others
Inflammatory Bowel Diseases, Volume 26, Issue 2, February 2020, Pages e11–e12, https://doi.org/10.1093/ibd/izz304
Published: 03 December 2019
Journal Article

Early Mucosal Healing Predicts Favorable Outcomes in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab: Data From the Real-life BE-SMART Cohort Get access

PDF
Peter Bossuyt and others
Inflammatory Bowel Diseases, Volume 25, Issue 1, January 2019, Pages 156–162, https://doi.org/10.1093/ibd/izy219
Published: 15 June 2018
Journal Article

Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease—A Multicenter Retrospective European Study Get access

PDF
Uri Kopylov and others
Inflammatory Bowel Diseases, Volume 24, Issue 11, November 2018, Pages 2442–2451, https://doi.org/10.1093/ibd/izy155
Published: 18 May 2018
Journal Article

Incidence and Predictors of Success of Adalimumab Dose Escalation and De-escalation in Ulcerative Colitis: a Real-World Belgian Cohort Study Get access

PDF
Saartje Van de Vondel and others
Inflammatory Bowel Diseases, Volume 24, Issue 5, May 2018, Pages 1099–1105, https://doi.org/10.1093/ibd/izx103
Published: 13 April 2018
Journal Article

Long-term Outcomes with Anti-TNF Therapy and Accelerated Step-up in the Prospective Pediatric Belgian Crohn's Disease Registry (BELCRO) Get access

PDF
Lucas Wauters and others
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1584–1591, https://doi.org/10.1097/MIB.0000000000001193
Published: 10 July 2017
Journal Article

Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus—A Multicenter Retrospective Study Get access

PDF
Uri Kopylov and others
Inflammatory Bowel Diseases, Volume 23, Issue 9, 1 September 2017, Pages 1605–1613, https://doi.org/10.1097/MIB.0000000000001160
Published: 05 June 2017
Journal Article

Development of the IBD Disk: A Visual Self-administered Tool for Assessing Disability in Inflammatory Bowel Diseases Open Access

PDF
Subrata Ghosh and others
Inflammatory Bowel Diseases, Volume 23, Issue 3, 1 March 2017, Pages 333–340, https://doi.org/10.1097/MIB.0000000000001033
Published: 31 January 2017